Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia

BACKGROUND: 30% of patients with polycystic ovary syndrome (PCOS) show mild, transient hyperprolactinemia. It is suggested that a reduction of the dopamine inhibitory effect might raise both prolactin and luteinizing hormone. Objective: To investigate the adjuvant cabergoline therapy effects on mens...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghaneei, Azam, Jowkar, Akram, Hasani Ghavam, Mohammad Reza, Ghaneei, Mohammad Ebrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research and Clinical Center for Infertility 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426146/
https://www.ncbi.nlm.nih.gov/pubmed/25999998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426146/
https://www.ncbi.nlm.nih.gov/pubmed/25999998

Ejemplares similares